MR imaging of oxygen extraction and neurovascular coupling.

Since the approval of tissue-type plasminogen activator (tPA) for the treatment of acute ischemic stroke by the Food and Drug Administration,1 the search for means to identify patients who may benefit from this treatment beyond the approved therapeutic window has been actively pursued. One of the most successful examples is the European Cooperative Acute Stroke Study III (ECASS III) trial,2,3 which demonstrated that efficacy of tPA treatment could be extended from the original 3 hours to 4.5 hours from onset. In addition, with an accumulating arsenal of mechanical clot retrieval devices, promising to achieve more effective reperfusion than intravenous-tPA,4–6 it is likely that the therapeutic windows for these retrieval devices will differ from that of intravenous-tPA. Different collateral flow patterns, comorbidities, and intrinsic tissue vulnerabilities among individual patients further complicate the use of a fixed therapeutic time-window for all patients and different treatments. Therefore, insights into brain tissue viability at the time of presentation may aid in the management of acute stroke. Toward this end, imaging approaches have been actively sought to provide a potential signature for tissue viability.7 Specifically, the diffusion/perfusion mismatch (DPM) concept has been widely advocated as a potential approach to depict the presence or absence of ischemic penumbra.8–10 The underlying hypothesis is that lesions defined by abnormal diffusion most likely reflect irreversible injury, whereas regions defined by abnormal perfusion represent critically hypoperfused tissue. The region of DPM with normal diffusion but abnormal perfusion is, in theory, the region at risk of evolving to infarction if reperfusion-promoting therapies are not administered. Although the overall hypothesis of DPM is straightforward and diffusion weighted images (DWI) and perfusion-weighted images (PWI) are readily available, the means by which DWI and PWI lesions are defined vary widely, leading to, potentially, …

[1]  Terry Jones,et al.  Oxygen metabolism, oxygen extraction and positron emission tomography: Historical perspective and impact on basic and clinical neuroscience , 2012, NeuroImage.

[2]  K. Lees,et al.  Letter by Kerr and Lees regarding article, "country comparisons of human stroke research since 2001: a bibliometric study". , 2012, Stroke.

[3]  S. Warach,et al.  Abstract 52: Results of DEFUSE 2: Imaging Endpoints , 2012 .

[4]  Weili Lin,et al.  Noninvasive Measurements of Cerebral Blood Flow, Oxygen Extraction Fraction, and Oxygen Metabolic Index in Human with Inhalation of Air and Carbogen using Magnetic Resonance Imaging , 2011, Translational Stroke Research.

[5]  I. Maldonado,et al.  Rescue, Combined, and Stand-Alone Thrombectomy in the Management of Large Vessel Occlusion Stroke Using the Solitaire Device: A Prospective 50-Patient Single-Center Study Timing, Safety, and Efficacy , 2011, Stroke.

[6]  Gregory W Albers,et al.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.

[7]  Steven Warach,et al.  Measurement of glutathione in normal volunteers and stroke patients at 3T using J‐difference spectroscopy with minimized subtraction errors , 2009, Journal of magnetic resonance imaging : JMRI.

[8]  Penumbra Pivotal Stroke Trial Investigators The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease , 2009, Stroke.

[9]  Yasheng Chen,et al.  Evaluation of MR-Derived Cerebral Oxygen Metabolic Index in Experimental Hyperoxic Hypercapnia, Hypoxia, and Ischemia , 2009, Stroke.

[10]  Henry Ma,et al.  Penumbral selection of patients for trials of acute stroke therapy , 2009, The Lancet Neurology.

[11]  W. Powers Imaging Preventable Infarction in Patients with Acute Ischemic Stroke , 2008, American Journal of Neuroradiology.

[12]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[13]  H. Lutsep,et al.  Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.

[14]  Weili Lin,et al.  Impact of intravascular signal on quantitative measures of cerebral oxygen extraction and blood volume under normo‐ and hypercapnic conditions using an asymmetric spin echo approach , 2003, Magnetic resonance in medicine.

[15]  Weili Lin,et al.  Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients , 2003, Annals of neurology.

[16]  Weili Lin,et al.  Cerebral oxygen extraction fraction and cerebral venous blood volume measurements using MRI: Effects of magnetic field variation , 2002, Magnetic resonance in medicine.

[17]  C. Weiller,et al.  Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans , 2002, Stroke.

[18]  H. An,et al.  Quantitative measurements of cerebral metabolic rate of oxygen utilization using MRI: a volunteer study , 2001, NMR in biomedicine.

[19]  D. Le Bihan,et al.  Viability Thresholds of Ischemic Penumbra of Hyperacute Stroke Defined by Perfusion-Weighted MRI and Apparent Diffusion Coefficient , 2001, Stroke.

[20]  Weili Lin,et al.  Quantitative Measurements of Cerebral Blood Oxygen Saturation Using Magnetic Resonance Imaging , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. , 2000, Stroke.

[22]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[23]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[24]  L H Schwamm,et al.  Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. , 1998, Stroke.

[25]  H. Ellis stroke , 1997, The Lancet.

[26]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[27]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[28]  Society of magnetic resonance in medicine , 1990 .